Intern, Biobanking
Moderna
Summary
This is a full-time co-op position from January 18, 2027 – June 25, 2027. Candidates must be available for the entire duration of the co-op program. As a co-op in Biobank Operations, you will support Moderna’s Biobank Operations team by supporting the quality, integrity, traceability, and efficient management of biospecimens. This role provides hands-on experience in sample lifecycle management, laboratory automation, and digital systems within a regulated biotechnology environment. Based in Norwood, MA, this lab-based role supports clinical studies and long-term biospecimen management activities that advance Moderna’s mission.
Job description
Here’s What You’ll Do
- Support biospecimen receipt, documentation, storage, retrieval, and distribution in accordance with applicable Standard Operating Procedures (SOPs) and safety requirements.
- Utilize LabVantage Laboratory Information Management System (LIMS) to support sample tracking, chain of custody, and lifecycle traceability.
- Support automation and robotics workflows used for sample reformatting, storage, and retrieval.
- Handle biospecimens across required temperature conditions while following applicable SOPs, safety requirements, and chain-of-custody practices.
- Support study close-out, sample reconciliation, and storage optimization activities that support long-term storage and operational efficiency.
- Identify and escalate sample, labeling, inventory, or documentation discrepancies to Biobank team members.
- Prepare and deliver project updates or presentations to Biobank and cross-functional teams, as appropriate.
Here’s What You’ll Need (Minimum Qualifications)
- Currently enrolled in a Bachelor’s program in Biology, Biomedical Sciences, Biochemistry, Chemistry, Molecular Biology, or a related field.
- Coursework or laboratory experience in biology, biochemistry, chemistry, molecular biology, or a related discipline.
- Basic laboratory skills such as pipetting and sample handling.
Here’s What You’ll Bring to the Table (Preferred Qualifications)
- Strong attention to detail and ability to follow complex protocols.
- Interest in biobanking, clinical research, laboratory operations, or regulated laboratory environments.
- Prior exposure to laboratory equipment, automation, or digital sample-tracking systems is a plus.
- Strong organizational skills and ability to work collaboratively in a fast-paced setting.
- A desire to make an impact as part of a company that is Bold, Relentless, Curious, and Collaborative.
Requirements
- Currently enrolled in a Bachelor’s program in Biology, Biomedical Sciences, Biochemistry, Chemistry, Molecular Biology, or a related field.
- Coursework or laboratory experience in biology, biochemistry, chemistry, molecular biology, or a related discipline.
- Basic laboratory skills such as pipetting and sample handling.
- Strong attention to detail and ability to follow complex protocols.
- Interest in biobanking, clinical research, laboratory operations, or regulated laboratory environments.
- Prior exposure to laboratory equipment, automation, or digital sample-tracking systems is a plus.
- Strong organizational skills and ability to work collaboratively in a fast-paced setting.
Benefits
- Meditation and mindfulness classes
- Subsidized commuter benefits
- Paid time off
- Vacation
- Sick time
- Holidays
- Volunteer days
- Discretionary year-end shutdown
Company overview
Moderna, Inc. is a pioneering American biotechnology and pharmaceutical company headquartered in Cambridge, Massachusetts, that has revolutionized the field of medicine through its groundbreaking messenger RNA (mRNA) technology. Founded in 2010, the company has established itself as a global leader in RNA therapeutics, primarily focusing on mRNA vaccines and treatments. Moderna's innovative platform uses mRNA to provide cellular instructions for producing proteins that trigger immune responses, creating a new category of medicines with significant potential to improve patient outcomes across various therapeutic areas. The company gained worldwide recognition during the COVID-19 pandemic for developing one of the earliest and most effective mRNA vaccines, which demonstrated the transformative potential of its technology platform. Beyond infectious diseases, Moderna is advancing a diverse pipeline of 44 treatment and vaccine candidates across infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune conditions. With approximately 5,800 employees and a strong commitment to scientific innovation, Moderna continues to expand its manufacturing capabilities and research initiatives to deliver the greatest possible impact through mRNA medicines.